Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis

Journal of the American Academy of Dermatology

Volumn 51, Issue 5, 2004, Pages 811-813

  Vázquez López, Francisco ^a,c   Marghoob, Ashfaq A ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SAFETY; EPILUMINESCENCE MICROSCOPY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN; SKIN ATROPHY; TELANGIECTASIA;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ADULT; ATROPHY; CALCITRIOL; CHRONIC DISEASE; CLOBETASOL; DERMATOLOGIC AGENTS; DERMOSCOPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PILOT PROJECTS; PSORIASIS;

EID: 8744313091     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.05.020     Document Type: Article

References (13)

1. M. Lebwohl, A. Yoles, K. Lombardi, and W. Lou Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: Effects on the duration of improvement J Am Acad Dermatol 39 1998 447 450
2. P.J. Frosch, E. Behrenbeck, K. Frosch, and E. Macher The Duhring chamber assay for corticosteroid atrophy Br J Dermatol 104 1981 57 65
3. H.I. Katz, S.E. Prawer, J.J. Mooney, and C.R. Samson Preatrophy: covert sign of thinned skin J Am Acad Dermatol 20 1989 731 735
4. F. Vázquez-López, J. Kreusch, and A.A. Marghoob Dermoscopic semiology: further insights into vascular features by screening a large spectrum of non tumoral skin lesions Br J Dermatol 150 2004 226 231
5. H.L. Richards, D.G. Fortune, T.M. O'Sullivan, C.J. Main, and C.E.M. Griffiths Patients with psoriasis and their compliance with medication J Am Acad Dermatol 41 1999 581 583
6. R. Balkrishnan, C.L. Carrol, F.T. Camacho, and S.R. Feldman Electronic monitoring of medication adherence in skin disease: Results of a pilot study J Am Acad Dermatol 49 2003 651 654
7. C. Queille-Roussel, C. Paul, L. Duteil, M.C. Lefevre, G. Rapatz, M. Zagula, and J.P. Portonne The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study Br J Dermatol 144 2001 507 513
8. C. Pelfini, M. Vignini, and A. Calligaro Morphometric computerized analysis as a method to assess skin atrophy caused by corticosteroids Skin Pharmacol 6 1993 26 31
9. J. Serup, and P. Holm Domoprednate (stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo Dermatologica 170 1985 189 194
10. K. Hoffmann, T. Auer, M. Stucker, A. Hoffmann, and P. Altemeyer Comparisons of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone J Eur Acad Dermatol Venereol 10 1998 137 142
11. A.J. McMichael, C.E. Griffiths, H.S. Talwar, L.J. Finkel, E.S. Rafal, and T.A. Hamilton Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy Br J Dermatol 135 1996 60 64
12. F. Vázquez-López, J.A. Manjón Haces, C. Maldonado Seral, C. Raya Aguado, N. Pérez Oliva, and A.A. Marghoob Dermoscopic features of plaque psoriasis and lichen planus: new observations Dermatology 207 2003 151 156
13. T.J. Ryan Microcirculation in psoriasis: blood vessels, lymphatics, and tissue fluids Pharmacol Ther 10 1980 27 64